
Sign up to save your podcasts
Or


Show Notes:
In this episode of the SMFM podcast, Dr. Marwan Maayeh is joined by Dr. Sura Alwan, an expert in teratology and birth defects epidemiology. Together, they explore the role of teratogens—agents that can cause birth abnormalities when exposed to the developing fetus. The conversation covers a wide range of topics, including the challenges MFM specialists face when counseling patients on medication use during pregnancy and the resources available for healthcare professionals and patients alike. Dr. Alwan highlights the work of OTIS (Organization of Teratology Information Specialists) and TERIS (Teratogen Information System) in providing evidence-based guidance on drug and environmental exposures in pregnancy. They also discuss the importance of research in identifying and managing teratogenic risks, the role of teratology databases, and combating misinformation in the field. Tune in for practical insights and resources on navigating these complex issues in MFM practice.
Additional Resources:
TERIS
OTIS/MotherToBaby
Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication Practice Guideline From the AAN, AES, and SMFM
smfmadvocates.org/positions
Transcript: Click here for the full transcript
By SMFM4.7
2424 ratings
Show Notes:
In this episode of the SMFM podcast, Dr. Marwan Maayeh is joined by Dr. Sura Alwan, an expert in teratology and birth defects epidemiology. Together, they explore the role of teratogens—agents that can cause birth abnormalities when exposed to the developing fetus. The conversation covers a wide range of topics, including the challenges MFM specialists face when counseling patients on medication use during pregnancy and the resources available for healthcare professionals and patients alike. Dr. Alwan highlights the work of OTIS (Organization of Teratology Information Specialists) and TERIS (Teratogen Information System) in providing evidence-based guidance on drug and environmental exposures in pregnancy. They also discuss the importance of research in identifying and managing teratogenic risks, the role of teratology databases, and combating misinformation in the field. Tune in for practical insights and resources on navigating these complex issues in MFM practice.
Additional Resources:
TERIS
OTIS/MotherToBaby
Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication Practice Guideline From the AAN, AES, and SMFM
smfmadvocates.org/positions
Transcript: Click here for the full transcript

66 Listeners

2,441 Listeners

3,349 Listeners

112,250 Listeners

56,677 Listeners

454 Listeners

552 Listeners

219 Listeners

101 Listeners

1,773 Listeners

66 Listeners

22 Listeners